NeoGenomics Inc (NEO)
13.94
-1.28
(-8.41%)
USD |
NASDAQ |
Apr 30, 16:00
13.94
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Cash from Operations (Quarterly): 17.78M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.78M |
| September 30, 2023 | -5.497M |
| June 30, 2023 | -1.548M |
| March 31, 2023 | -12.69M |
| December 31, 2022 | -3.685M |
| September 30, 2022 | -16.27M |
| June 30, 2022 | -17.00M |
| March 31, 2022 | -29.04M |
| December 31, 2021 | -19.78M |
| September 30, 2021 | -7.767M |
| June 30, 2021 | -1.39M |
| March 31, 2021 | 2.21M |
| December 31, 2020 | 5.985M |
| September 30, 2020 | 0.526M |
| June 30, 2020 | 1.882M |
| March 31, 2020 | -6.933M |
| December 31, 2019 | 3.359M |
| September 30, 2019 | 18.63M |
| June 30, 2019 | -4.721M |
| March 31, 2019 | 6.097M |
| December 31, 2018 | 15.45M |
| September 30, 2018 | 8.381M |
| June 30, 2018 | 6.64M |
| March 31, 2018 | 14.31M |
| December 31, 2017 | 5.759M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.436M |
| June 30, 2017 | 6.528M |
| March 31, 2017 | -1.686M |
| December 31, 2016 | -0.241M |
| September 30, 2016 | 9.623M |
| June 30, 2016 | 5.036M |
| March 31, 2016 | 7.059M |
| December 31, 2015 | 2.121M |
| September 30, 2015 | 2.375M |
| June 30, 2015 | 2.684M |
| March 31, 2015 | -0.787M |
| December 31, 2014 | 0.986M |
| September 30, 2014 | 3.166M |
| June 30, 2014 | 4.273M |
| March 31, 2014 | 1.025M |
| December 31, 2013 | -0.505M |
| September 30, 2013 | 2.199M |
| June 30, 2013 | 1.863M |
| March 31, 2013 | -1.33M |
| December 31, 2012 | 0.001M |
| September 30, 2012 | -0.509M |
| June 30, 2012 | 1.081M |
| March 31, 2012 | -1.065M |
| December 31, 2011 | 1.239M |
| September 30, 2011 | -0.116M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-29.04M
Minimum
Mar 2022
18.63M
Maximum
Sep 2019
-3.997M
Average
-3.685M
Median
Dec 2022
Cash from Operations (Quarterly) Benchmarks
| Teladoc Health Inc | 8.92M |
| Abbott Laboratories | 3.038B |
| Halozyme Therapeutics Inc | 102.35M |
| Verastem Inc | -29.68M |
| Ocugen Inc | -11.30M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.20M |
| Cash from Financing (Quarterly) | 1.27M |
| Free Cash Flow | -30.70M |
| Free Cash Flow Per Share (Quarterly) | 0.0852 |
| Free Cash Flow to Equity (Quarterly) | 10.00M |
| Free Cash Flow to Firm (Quarterly) | 10.73M |
| Free Cash Flow Yield | -1.76% |